708 related articles for article (PubMed ID: 16896309)
1. POLG1 mutations associated with progressive encephalopathy in childhood.
Kollberg G; Moslemi AR; Darin N; Nennesmo I; Bjarnadottir I; Uvebrant P; Holme E; Melberg A; Tulinius M; Oldfors A
J Neuropathol Exp Neurol; 2006 Aug; 65(8):758-68. PubMed ID: 16896309
[TBL] [Abstract][Full Text] [Related]
2. POLG mutations in Alpers syndrome.
Nguyen KV; Østergaard E; Ravn SH; Balslev T; Danielsen ER; Vardag A; McKiernan PJ; Gray G; Naviaux RK
Neurology; 2005 Nov; 65(9):1493-5. PubMed ID: 16177225
[TBL] [Abstract][Full Text] [Related]
3. POLG mutations and Alpers syndrome.
Davidzon G; Mancuso M; Ferraris S; Quinzii C; Hirano M; Peters HL; Kirby D; Thorburn DR; DiMauro S
Ann Neurol; 2005 Jun; 57(6):921-3. PubMed ID: 15929042
[TBL] [Abstract][Full Text] [Related]
4. Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus.
Uusimaa J; Hinttala R; Rantala H; Päivärinta M; Herva R; Röyttä M; Soini H; Moilanen JS; Remes AM; Hassinen IE; Majamaa K
Epilepsia; 2008 Jun; 49(6):1038-45. PubMed ID: 18294203
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and genotypic variability in Alpers syndrome.
Sofou K; Moslemi AR; Kollberg G; Bjarnadóttir I; Oldfors A; Nennesmo I; Holme E; Tulinius M; Darin N
Eur J Paediatr Neurol; 2012 Jul; 16(4):379-89. PubMed ID: 22237560
[TBL] [Abstract][Full Text] [Related]
6. Molecular diagnosis of Alpers syndrome.
Nguyen KV; Sharief FS; Chan SS; Copeland WC; Naviaux RK
J Hepatol; 2006 Jul; 45(1):108-16. PubMed ID: 16545482
[TBL] [Abstract][Full Text] [Related]
7. Clonally expanded mitochondrial DNA mutations in epileptic individuals with mutated DNA polymerase gamma.
Zsurka G; Baron M; Stewart JD; Kornblum C; Bös M; Sassen R; Taylor RW; Elger CE; Chinnery PF; Kunz WS
J Neuropathol Exp Neurol; 2008 Sep; 67(9):857-66. PubMed ID: 18716558
[TBL] [Abstract][Full Text] [Related]
8. Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome.
Götz A; Isohanni P; Pihko H; Paetau A; Herva R; Saarenpää-Heikkilä O; Valanne L; Marjavaara S; Suomalainen A
Brain; 2008 Nov; 131(Pt 11):2841-50. PubMed ID: 18819985
[TBL] [Abstract][Full Text] [Related]
9. Rapidly progressive neurological deterioration in a child with Alpers syndrome exhibiting a previously unremarkable brain MRI.
Brunetti-Pierri N; Selby K; O'Sullivan M; Hendson G; Truong C; Waters PJ; Wong LJ
Neuropediatrics; 2008 Jun; 39(3):179-83. PubMed ID: 18991199
[TBL] [Abstract][Full Text] [Related]
10. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion.
Naviaux RK; Nguyen KV
Ann Neurol; 2004 May; 55(5):706-12. PubMed ID: 15122711
[TBL] [Abstract][Full Text] [Related]
11. Two novel POLG mutations causing hepatic mitochondrial DNA depletion with recurrent hypoketotic hypoglycaemia and fatal liver dysfunction.
Bortot B; Barbi E; Biffi S; Lunazzi G; Bussani R; Burlina A; Norbedo S; Ventura A; Carrozzi M; Severini GM
Dig Liver Dis; 2009 Jul; 41(7):494-9. PubMed ID: 19195941
[TBL] [Abstract][Full Text] [Related]
12. Low frequency of mtDNA point mutations in patients with PEO associated with POLG1 mutations.
Kollberg G; Jansson M; Pérez-Bercoff A; Melberg A; Lindberg C; Holme E; Moslemi AR; Oldfors A
Eur J Hum Genet; 2005 Apr; 13(4):463-9. PubMed ID: 15702133
[TBL] [Abstract][Full Text] [Related]
13. POLG1 manifestations in childhood.
Isohanni P; Hakonen AH; Euro L; Paetau I; Linnankivi T; Liukkonen E; Wallden T; Luostarinen L; Valanne L; Paetau A; Uusimaa J; Lönnqvist T; Suomalainen A; Pihko H
Neurology; 2011 Mar; 76(9):811-5. PubMed ID: 21357833
[TBL] [Abstract][Full Text] [Related]
14. Features of cell death in brain and liver, the target tissues of progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher disease).
Simonati A; Filosto M; Savio C; Tomelleri G; Tonin P; Dalla Bernardina B; Rizzuto N
Acta Neuropathol; 2003 Jul; 106(1):57-65. PubMed ID: 12721699
[TBL] [Abstract][Full Text] [Related]
15. Hepatocerebral mitochondrial DNA depletion syndrome caused by deoxyguanosine kinase (DGUOK) mutations.
Freisinger P; Fütterer N; Lankes E; Gempel K; Berger TM; Spalinger J; Hoerbe A; Schwantes C; Lindner M; Santer R; Burdelski M; Schaefer H; Setzer B; Walker UA; Horváth R
Arch Neurol; 2006 Aug; 63(8):1129-34. PubMed ID: 16908739
[TBL] [Abstract][Full Text] [Related]
16. Juvenile Alpers disease.
Wiltshire E; Davidzon G; DiMauro S; Akman HO; Sadleir L; Haas L; Zuccollo J; McEwen A; Thorburn DR
Arch Neurol; 2008 Jan; 65(1):121-4. PubMed ID: 18195149
[TBL] [Abstract][Full Text] [Related]
17. A novel homozygous RRM2B missense mutation in association with severe mtDNA depletion.
Kollberg G; Darin N; Benan K; Moslemi AR; Lindal S; Tulinius M; Oldfors A; Holme E
Neuromuscul Disord; 2009 Feb; 19(2):147-50. PubMed ID: 19138848
[TBL] [Abstract][Full Text] [Related]
18. POLG mutations in sporadic mitochondrial disorders with multiple mtDNA deletions.
Di Fonzo A; Bordoni A; Crimi M; Sara G; Del Bo R; Bresolin N; Comi GP
Hum Mutat; 2003 Dec; 22(6):498-9. PubMed ID: 14635118
[TBL] [Abstract][Full Text] [Related]
19. Alpers syndrome with prominent white matter changes.
Bao X; Wu Y; Wong LJ; Zhang Y; Xiong H; Chou PC; Truong CK; Jiang Y; Qin J; Yuan Y; Lin Q; Wu X
Brain Dev; 2008 Apr; 30(4):295-300. PubMed ID: 17923349
[TBL] [Abstract][Full Text] [Related]
20. Polymerase gamma deficiency (POLG): clinical course in a child with a two stage evolution from infantile myocerebrohepatopathy spectrum to an Alpers syndrome and neuropathological findings of Leigh's encephalopathy.
Scalais E; Francois B; Schlesser P; Stevens R; Nuttin C; Martin JJ; Van Coster R; Seneca S; Roels F; Van Goethem G; Löfgren A; De Meirleir L
Eur J Paediatr Neurol; 2012 Sep; 16(5):542-8. PubMed ID: 22342071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
